Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The substance does not meet the criteria for classification as to acute toxicity

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2006-05-09 to 2006-05-23
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
comparable to guideline study
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
Deviations:
yes
Remarks:
Non-GLP study
GLP compliance:
no
Test type:
fixed dose procedure
Limit test:
yes
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Lot 05019

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: stable

Species:
rat
Strain:
other: Crl: CD (SD)
Sex:
female
Details on test animals or test system and environmental conditions:
Age at time of dosing: 7 weeks
Route of administration:
oral: drinking water
Vehicle:
methylcellulose
Details on oral exposure:
VEHICLE
0.5 % methylcellulose

Doses:
2000 mg/kg b.w.
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Observations: 10 min, 30 min, 1 h, 2 h, 4 h, then daily
Weighing: Before dosing, after 1 d, 3 d, 7 d, 14 d
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat. (total fraction)
Mortality:
No mortality occured.
Clinical signs:
other: No symptoms developed throughout the study period.
Gross pathology:
Necropsy findings: No changes attributable to the test item were observed.
Interpretation of results:
GHS criteria not met
Conclusions:
The substance is practically nontoxic when administered orally.
Executive summary:

L-(+)-2,5-diaminopentanoic acid was administered in a dose of 2000 mg/kg b.w. to female rats. No mortality occured. On other treatement related observations werde made.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
> 2 000 mg/kg bw
Quality of whole database:
Klimisch 1

Acute toxicity: via inhalation route

Link to relevant study records
Reference
Endpoint:
acute toxicity: inhalation
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
the study does not need to be conducted because exposure of humans via inhalation is not likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size
Justification for type of information:
JUSTIFICATION FOR DATA WAIVING
Regarding inhalation, the combination of low volatility, a negative Log Kow and high water solubility suggests that absorption directly across the respiratory tract epithelium is unlikely.
Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Link to relevant study records
Reference
Endpoint:
acute toxicity: dermal
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
the study does not need to be conducted because the physicochemical and toxicological properties suggest no potential for a significant rate of absorption through the skin
Justification for type of information:
JUSTIFICATION FOR DATA WAIVING
Dermal absorption is unlikely because of the poor lipophilicity of L-(+)-2,5-diaminopentanoic acid. It suggests that the substance is not likely to cross the stratum corneum. Moreover, the low volatility in combination with the high water solubility and the negative Log P value indicate that the substance may be too hydrophilic to cross the lipid rich stratum corneum and thus dermal uptake will be unlikely.
Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Justification for classification or non-classification

L-(+)-2,5-diaminopentanoic acid was administered in a dose of 2000 mg/kg b.w. to female rats. No mortality occured. No other treatement related observations werde made.